Haloperidol Decanoate EP Impurity B CAS CATO-C4X-146134
| CAS No. | CATO-C4X-146134 |
| Molecular Formula | C31H41ClFNO3 |
| Molecular Weight | N/A |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
Compared with other compounds in its class, the molecular weight of 566.58 g/mol gives Haloperidol Decanoate EP Impurity B distinctive chromatographic separation conditions and mass-spectrometry parameter settings.
As a process- or degradation-related impurity, Haloperidol Decanoate EP Impurity B (CAS CATO-C4X-146134, C31H41ClFNO3HCl) is essential for impurity profiling, related-substances testing, and forced-degradation studies in pharmaceutical development.
Haloperidol Decanoate EP Impurity B (C31H41ClFNO3HCl) contains a nitrogen-containing heterocyclic scaffold, an amide group, a hydroxyl group, an ether linkage, fluorine/chlorine substitution. Halogen substitution raises its density and boiling point, its high carbon-to-hydrogen ratio confers good lipid solubility, the carboxyl group imparts weak acidity; these physicochemical properties determine the optimal preparation and storage of its standard solutions. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
CATO manufactures Haloperidol Decanoate EP Impurity B under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C31H41ClFNO3 HCl |
| Molecular Weight | 566.58 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor, low volatility) |
| Purity | 97%+ |
| Storage | Store at room temperature, protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in chloroform, dichloromethane, ethyl acetate, DMSO |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 10.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Halogen Content | F/Cl-containing |
| Nitrogen Atoms | 1 |
Related Haloperidol Standards
- Haloperidol Impurity 10 (CAS 100442-88-4)
- Haloperidol Decanoate EP Impurity H (CAS 1134807-34-3)
- Haloperidol-d4 (CAS 1189986-59-1)
- Haloperidol impurity 02 (CAS 121751-79-9)
- Haloperidol impurity 40 (CAS 1253910-15-4)
- Haloperidol pyridinium Chloride Impurity (CAS 125785-69-5)
- Haloperidol EP Impurity B (CAS 1391052-53-1)
- Haloperidol EP Impurity F (CAS 1391052-67-7)
Recommended Standards
- Empagliflozin impurity 187 (CAS CATO-C4X-1065187)
- Norfloxacin Impurity 23 (CAS CATO-C4X-146823)
- Scopolamine impurity 26 (CAS CATO-C4X-195826)
- Trelagliptin Impurity 53 (CAS 1812193-01-3)
- 4-(2-Bromobenzoyl)-N-cyclohexyl-1H-pyrrole-2-carboxamide (CAS 551931-27-2)
- tert-Butyl (4-((trimethylsilyl)ethynyl)thiazol-2-yl)carbamate (CAS 2533893-47-7)
- 10-Hydroxy Warfarin (CAS 83219-99-2)
- N-benzyl-5-chloro-N-methyl-4-(methylamino)pyridine-3-sulfonamide (CAS 1352528-87-0)
- 2-[(4-Methoxyphenyl)sulfanyl]-N-[3-(trifluoromethyl)phenyl]acetamide (CAS 339097-75-5)
- 263251-78-1 NMG938VJ6T D-3 Tavilermide [USAN:INN] UNII-NMG938VJ6T MIM-D3 MIM-D 3 D 3 (peptide) Tavilermide (CAS 263251-78-1)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com